Rising prevalence of conjunctivitis is propelling the growth of the viral conjunctivitis drugs market
The most commonly used viral conjunctivitis drugs are antibiotics. These drugs, including amikacin, doxycycline, and gentamycin are effective in the treatment of this condition. Doxycycline can cause nausea, vomiting, diarrhea, dizziness, hives, and even bleeding, and these effects can be severe if they persist for a long time. Gentamycin, on the other hand, causes diarrhea and produces thin discharge from the nose. The growing prevalence of conjunctivitis or pink eye is a key factor fueling the growth of the viral conjunctivitis drugs market. Conjunctivitis drugs are used to treat inflammation or swelling of the conjunctiva. A rise in hygiene and awareness coupled with the increasing healthcare expenditure is also propelling the growth of viral conjunctivitis drugs. According to the World Health Organization, global spending on health continues to rise. It was US$ 7.8 trillion in 2017 or about 10% of GDP and $1,080 per capita – up from US$ 7.6 trillion in 2016. The incr...